Why Bay Area's XOMA Surged 700% in 2017 by Not Making Drugs Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company burned through $1.2B and never brought a drug to market in its 37 years. Source: BioSpace You Might Also Like Stanford University Clinical Geneticist Begins Presidency With The March 22, 2017 Merck Plots 950-Job R&D Hub in London November 26, 2017 Crinetics Pharmaceuticals Snags $63.5 Million in Series B Funding March 13, 2018
